Aclaris Therapeutics, Inc. SEC filings ACRS
Aclaris Therapeutics, Inc. has 872 filings in SEC EDGAR's recent list, going back to Sep 10, 2012. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 5, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2026 | Nov 5, 2026 |
| 8-K |
Current report
Material agreement
|
Oct 27, 2026 | Oct 27, 2026 |
| 424B5 | Prospectus supplement | Oct 27, 2026 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Oct 27, 2026 | Oct 27, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Sep 21, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| 8-K |
Current report
Material agreement
|
Aug 6, 2026 | Aug 6, 2026 |
| S-3ASR | Automatic shelf registration | Aug 6, 2026 | — |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 4 | Insider transaction | Aug 4, 2026 | Aug 1, 2026 |
| 4 | Insider transaction | Jun 8, 2026 | Jun 4, 2026 |
| 4 | Insider transaction | Jun 8, 2026 | Jun 4, 2026 |
| 4 | Insider transaction | Jun 8, 2026 | Jun 4, 2026 |
| 4 | Insider transaction | Jun 8, 2026 | Jun 4, 2026 |
| 4 | Insider transaction | Jun 8, 2026 | Jun 4, 2026 |
| 4 | Insider transaction | Jun 8, 2026 | Jun 4, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 4, 2026 | Jun 4, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 12, 2026 | — |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| 4 | Insider transaction | May 5, 2026 | May 1, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 28, 2026 | Apr 28, 2026 |
| 4 | Insider transaction | Apr 27, 2026 | Apr 27, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 27, 2026 | — |
| ARS | Annual report to shareholders | Apr 23, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 23, 2026 | — |
| DEF 14A | Proxy statement | Apr 23, 2026 | Jun 4, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 7, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 26, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Mar 17, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 11, 2026 | Mar 10, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 10, 2026 | Mar 9, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Mar 1, 2026 |
| 10-K | Annual report | Feb 26, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 26, 2026 | Feb 26, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 9, 2026 | — |
| 4 | Insider transaction | Feb 6, 2026 | Feb 2, 2026 |
| 4 | Insider transaction | Feb 6, 2026 | Feb 2, 2026 |
| 4 | Insider transaction | Feb 6, 2026 | Feb 2, 2026 |
| 4 | Insider transaction | Feb 6, 2026 | Feb 2, 2026 |
| 4 | Insider transaction | Feb 6, 2026 | Feb 2, 2026 |
| 4 | Insider transaction | Feb 6, 2026 | Feb 2, 2026 |
| 4 | Insider transaction | Feb 5, 2026 | Feb 3, 2026 |
| 4 | Insider transaction | Feb 5, 2026 | Feb 3, 2026 |
| 4 | Insider transaction | Feb 5, 2026 | Feb 3, 2026 |
| 4 | Insider transaction | Feb 5, 2026 | Feb 3, 2026 |
| 4/A | Filing | Feb 5, 2026 | Feb 1, 2026 |
| 4 | Insider transaction | Feb 3, 2026 | Feb 1, 2026 |
| 4 | Insider transaction | Feb 3, 2026 | Feb 1, 2026 |
| 4/A | Filing | Feb 3, 2026 | Feb 1, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jan 21, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 12, 2026 | Jan 12, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jan 9, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 6, 2026 | Jan 6, 2026 |
| 4 | Insider transaction | Jan 5, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 5, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Jan 5, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Dec 4, 2025 | Dec 2, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 13, 2025 | — |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 14, 2025 | Oct 14, 2025 |
| 10-Q | Quarterly report | Aug 7, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2025 | Aug 7, 2025 |
| 4 | Insider transaction | Aug 5, 2025 | Aug 1, 2025 |
| 3 | Initial insider ownership | Aug 5, 2025 | Jul 28, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 29, 2025 | Jul 29, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 29, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 24, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 17, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 30, 2025 | Jun 30, 2025 |
| 4 | Insider transaction | Jun 9, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 9, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 9, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 9, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 9, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 9, 2025 | Jun 5, 2025 |
| S-8 | Employee stock plan registration | Jun 5, 2025 | — |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
Jun 5, 2025 | Jun 5, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 12, 2025 | — |
| 10-Q | Quarterly report | May 8, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 8, 2025 | May 8, 2025 |
| 4 | Insider transaction | May 5, 2025 | May 1, 2025 |
| 3 | Initial insider ownership | May 5, 2025 | May 1, 2025 |
| 4 | Insider transaction | May 5, 2025 | May 1, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 5, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 30, 2025 | — |
| ARS | Annual report to shareholders | Apr 24, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 24, 2025 | — |
| DEF 14A | Proxy statement | Apr 24, 2025 | Jun 5, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 14, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Apr 3, 2025 | Apr 1, 2025 |
| EFFECT | Filing | Mar 7, 2025 | — |
| CORRESP | Letter to the SEC | Mar 5, 2025 | — |
| 4 | Insider transaction | Mar 4, 2025 | Mar 1, 2025 |
| 4 | Insider transaction | Mar 4, 2025 | Mar 1, 2025 |
| 4 | Insider transaction | Mar 4, 2025 | Mar 1, 2025 |
| UPLOAD | Letter from the SEC | Mar 4, 2025 | — |
| S-3 | Shelf registration | Feb 27, 2025 | — |
| 10-K | Annual report | Feb 27, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 27, 2025 | Feb 27, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 13, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 12, 2025 | — |
| 4 | Insider transaction | Feb 4, 2025 | Feb 3, 2025 |
| 4 | Insider transaction | Feb 4, 2025 | Feb 1, 2025 |
| 4 | Insider transaction | Feb 4, 2025 | Feb 1, 2025 |
| 4 | Insider transaction | Feb 4, 2025 | Feb 1, 2025 |
| 4 | Insider transaction | Feb 4, 2025 | Feb 1, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 4 | Insider transaction | Jan 3, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Jan 3, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Jan 3, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Jan 3, 2025 | Jan 1, 2025 |
| EFFECT | Filing | Dec 31, 2024 | — |
| 424B3 | Prospectus | Dec 31, 2024 | — |
| CORRESP | Letter to the SEC | Dec 27, 2024 | — |
| UPLOAD | Letter from the SEC | Dec 26, 2024 | — |
| S-3 | Shelf registration | Dec 19, 2024 | — |
| 4 | Insider transaction | Dec 12, 2024 | Dec 10, 2024 |
| 4 | Insider transaction | Dec 6, 2024 | Dec 4, 2024 |
| D | Filing | Dec 4, 2024 | — |
| 4 | Insider transaction | Dec 3, 2024 | Dec 2, 2024 |
| 4 | Insider transaction | Dec 3, 2024 | Dec 1, 2024 |
| S-8 | Employee stock plan registration | Nov 27, 2024 | — |
| 3 | Initial insider ownership | Nov 25, 2024 | Nov 18, 2024 |
| SC 13G | Ownership over 5% (passive) | Nov 25, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Nov 22, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Nov 21, 2024 | — |
| 4 | Insider transaction | Nov 20, 2024 | Nov 19, 2024 |
| 3 | Initial insider ownership | Nov 18, 2024 | Nov 18, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change, Regulation FD disclosure, Other events
|
Nov 18, 2024 | Nov 16, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| 10-Q | Quarterly report | Nov 6, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2024 | Nov 6, 2024 |
| 4 | Insider transaction | Nov 5, 2024 | Nov 1, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Oct 9, 2024 | — |
| 4 | Insider transaction | Oct 3, 2024 | Oct 1, 2024 |
| 4 | Insider transaction | Sep 4, 2024 | Sep 1, 2024 |
| 4 | Insider transaction | Sep 4, 2024 | Sep 1, 2024 |
| 4 | Insider transaction | Aug 13, 2024 | Aug 9, 2024 |
| 10-Q | Quarterly report | Aug 7, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2024 | Aug 7, 2024 |
| 4 | Insider transaction | Aug 5, 2024 | Aug 1, 2024 |
| 4 | Insider transaction | Aug 5, 2024 | Aug 2, 2024 |
| 4 | Insider transaction | Jul 31, 2024 | Jul 30, 2024 |
| 4 | Insider transaction | Jul 22, 2024 | Jul 18, 2024 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jul 16, 2024 | Jul 16, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Jul 8, 2024 | — |
| 4 | Insider transaction | Jul 5, 2024 | Jul 2, 2024 |
| 4 | Insider transaction | Jul 3, 2024 | Jul 1, 2024 |
| 4 | Insider transaction | Jul 1, 2024 | Jun 27, 2024 |
| 4 | Insider transaction | Jun 18, 2024 | Jun 14, 2024 |
| 4 | Insider transaction | Jun 13, 2024 | Jun 11, 2024 |
| 4 | Insider transaction | Jun 10, 2024 | Jun 6, 2024 |
| 4 | Insider transaction | Jun 10, 2024 | Jun 6, 2024 |
| 4 | Insider transaction | Jun 10, 2024 | Jun 6, 2024 |
| 4 | Insider transaction | Jun 10, 2024 | Jun 6, 2024 |
| 4 | Insider transaction | Jun 10, 2024 | Jun 6, 2024 |
| 4 | Insider transaction | Jun 10, 2024 | Jun 6, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 7, 2024 | Jun 6, 2024 |
| 4 | Insider transaction | Jun 4, 2024 | Jun 1, 2024 |
| 4 | Insider transaction | Jun 4, 2024 | Jun 1, 2024 |
| 4 | Insider transaction | Jun 4, 2024 | Jun 1, 2024 |
| 4 | Insider transaction | Jun 4, 2024 | Jun 1, 2024 |
| 4 | Insider transaction | Jun 4, 2024 | Jun 1, 2024 |
| 4 | Insider transaction | Jun 4, 2024 | Jun 1, 2024 |
| 4 | Insider transaction | Jun 4, 2024 | Jun 1, 2024 |
| 4 | Insider transaction | Jun 4, 2024 | Jun 1, 2024 |
| 4 | Insider transaction | Jun 4, 2024 | Jun 1, 2024 |
| 10-Q | Quarterly report | May 7, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 7, 2024 | May 7, 2024 |
| S-8 | Employee stock plan registration | May 7, 2024 | — |
| 4 | Insider transaction | May 3, 2024 | May 1, 2024 |
| ARS | Annual report to shareholders | Apr 25, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 25, 2024 | — |
| DEF 14A | Proxy statement | Apr 25, 2024 | Jun 6, 2024 |
| 4 | Insider transaction | Apr 3, 2024 | Apr 1, 2024 |
| 8-K |
Current report
Officer or director change
|
Mar 19, 2024 | Mar 14, 2024 |
| 4 | Insider transaction | Mar 5, 2024 | Mar 1, 2024 |
| 4 | Insider transaction | Mar 5, 2024 | Mar 1, 2024 |
| 4 | Insider transaction | Mar 5, 2024 | Mar 1, 2024 |
| 4 | Insider transaction | Mar 5, 2024 | Mar 1, 2024 |
| 10-K | Annual report | Feb 27, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 27, 2024 | Feb 27, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 13, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 8, 2024 | — |
| 3 | Initial insider ownership | Feb 8, 2024 | Feb 7, 2024 |
| 4 | Insider transaction | Feb 5, 2024 | Feb 1, 2024 |
| 4 | Insider transaction | Feb 5, 2024 | Feb 1, 2024 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ACRS (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Wayne, PA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1557746
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.